Arginetix and Immune Control Inc. Merge to Form Corridor Pharmaceuticals; New Company Completes $15 Million Series A Financing
6/17/2010 7:15:24 AM
More...
|
Immune Control Inc. Enrolls $5 Million As It Shifts Focus To Asthma Treatment
8/14/2009 10:05:19 AM
More...
|
Immune Control Inc. Raises $11.3 Million To Commence Two Clinical Trials
10/19/2005 5:09:34 PM
More...
|
Provid Pharmaceuticals Inc. Announces Drug Discovery Collaboration With Immune Control Inc.
10/19/2005 5:09:01 PM
More...
|
BioSpace Unveils Inaugural BioPenn™ Hotbed Campaign
10/19/2005 5:08:43 PM
More...
|